Showing results (301-310 of 668) with videos related to

Sort By:
Pageof 67
Diabetology International|March 25, 2024
Clinical factors associated with birth weight of infants born to pregnant women with diabetesTomoko Suzuki, Keiko Yanagisawa, Jun Kakogawa, et al.
Diabetology International|March 25, 2024
Correction: Patients with gestational diabetes mellitus may be treated in both early and late pregnancy, especially in patients with pre-pregnancy overweight: A cross-sectional study in JapanAyaka Takemoto, Yoshio Nagai, Shin Kawanabe, et al.
Diabetology International|March 25, 2024
Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetesJunko Oya, Tomoko Nakagami, Yukiko Hasegawa, et al.
Diabetology International|January 24, 2024
Life-threatening coronary vasospasm in patients with type 2 diabetes with SGLT2 inhibitor-induced euglycemic ketoacidosis: a report of two consecutive casesJunko Kawahara, Bunji Kaku, Kunimasa Yagi, et al.
Diabetology International|January 24, 2024
Effectiveness of management protocol for insulin balls in diabetics: a scoping reviewTomomi Horiguchi, Sayuri Nakamura, Yuko Matsui, et al.
Diabetology International|January 24, 2024
Adipose Tissue Plasticity and Insulin Signaling in the Pathogenesis of Type 2 DiabetesMasaji Sakaguchi
Diabetology International|January 24, 2024
The predictive role of serum uric acid levels before pregnancy in the development of gestational diabetes mellitusAzam Ghanei, Golnaz Mohammadzade, Mohammadreza Gholami Banadkoki, et al.
Diabetology International|January 24, 2024
Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumabYuma Motomura, Shin Urai, Yushi Hirota, et al.
Diabetology International|January 24, 2024
A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activationSuratsawadee Promsuwan, Kazuki Sawamoto, Liang Xu, et al.
Diabetology International|August 5, 2024
A case of rapidly progressive insulin-dependent diabetes mellitus without islet autoantibodies developed over two years after the first dose of nivolumabKota Nishihama, Yuko Okano, Chisa Inoue, et al.
Pageof 67